Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Al-Attar

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Clinics in Laboratory Medicine|August 1, 2024
Automation in Flow CytometryGiovanni Insuasti-Beltran, Ahmad Al-Attar
Blood|October 27, 2022
κ light chain-expressing hematogones in a patient with λ-restricted CLL and multiple myeloma on daratumumab therapyAhmad Al-Attar, Bruce A Woda
Psychology and Aging|June 20, 2012
Psychosocial resources, aging, and natural killer cell terminal maturitySuzanne C Segerstrom, Ahmad Al-Attar, Charles T Lutz
Transplantation|June 11, 2014
Alloantibody to a Bw4 epitope in a Bw4+B*27: 05 patientCharles T Lutz, Ahmad Al-Attar, John R May, et al.
Cytometry. Part B, Clinical Cytometry|December 25, 2025
Authors' Response to Letter from Khanolkar and Ahmed concerning our article "An unusual pattern observed upon the addition of CD79b to a flow cytometry B-cell lymphoma panel" (Panakkal et al., 2025). Cytometry Part B: Clinical Cytometry. DOI: 10.1002/cyto.b.22246. PMID: 40657818Vandana Panakkal, Raniah Al Amri, Stacey Mamatas, et al.
Cytometry. Part B, Clinical Cytometry|February 9, 2026
COMIP-001: A clinical 13-antibody, 12-color flow cytometry panel for optimized immunophenotyping of T/NK cells in human leukemia and lymphoma diagnosticsNicole So, Sara Monaghan, Katelynn Davis, et al.
Pathology Oncology Research : POR|December 22, 2009
T cell density and location can influence the prognosis of ovarian cancerAhmad Al-Attar, Mohamed Shehata, Lindy Durrant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2012
Differential transcription factor use by the KIR2DL4 promoter under constitutive and IL-2/15-treated conditionsSteven R Presnell, Lei Zhang, Corrin N Chlebowy, et al.
Genes and Immunity|November 21, 2014
Human natural killer cell microRNA: differential expression of MIR181A1B1 and MIR181A2B2 genes encoding identical mature microRNAsSteven R Presnell, Ahmad Al-Attar, Frank Cichocki, et al.
Virchows Archiv : an International Journal of Pathology|March 17, 2026
T-prolymphocytic leukemia with three distinct immunophenotypic subsetsNana P Matsumoto, Katelynn E Davis, Nidhi Aggarwal, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Clinics in Laboratory Medicine|August 1, 2024
Automation in Flow CytometryGiovanni Insuasti-Beltran, Ahmad Al-Attar
Blood|October 27, 2022
κ light chain-expressing hematogones in a patient with λ-restricted CLL and multiple myeloma on daratumumab therapyAhmad Al-Attar, Bruce A Woda
Psychology and Aging|June 20, 2012
Psychosocial resources, aging, and natural killer cell terminal maturitySuzanne C Segerstrom, Ahmad Al-Attar, Charles T Lutz
Transplantation|June 11, 2014
Alloantibody to a Bw4 epitope in a Bw4+B*27: 05 patientCharles T Lutz, Ahmad Al-Attar, John R May, et al.
Cytometry. Part B, Clinical Cytometry|December 25, 2025
Authors' Response to Letter from Khanolkar and Ahmed concerning our article "An unusual pattern observed upon the addition of CD79b to a flow cytometry B-cell lymphoma panel" (Panakkal et al., 2025). Cytometry Part B: Clinical Cytometry. DOI: 10.1002/cyto.b.22246. PMID: 40657818Vandana Panakkal, Raniah Al Amri, Stacey Mamatas, et al.
Cytometry. Part B, Clinical Cytometry|February 9, 2026
COMIP-001: A clinical 13-antibody, 12-color flow cytometry panel for optimized immunophenotyping of T/NK cells in human leukemia and lymphoma diagnosticsNicole So, Sara Monaghan, Katelynn Davis, et al.
Pathology Oncology Research : POR|December 22, 2009
T cell density and location can influence the prognosis of ovarian cancerAhmad Al-Attar, Mohamed Shehata, Lindy Durrant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2012
Differential transcription factor use by the KIR2DL4 promoter under constitutive and IL-2/15-treated conditionsSteven R Presnell, Lei Zhang, Corrin N Chlebowy, et al.
Genes and Immunity|November 21, 2014
Human natural killer cell microRNA: differential expression of MIR181A1B1 and MIR181A2B2 genes encoding identical mature microRNAsSteven R Presnell, Ahmad Al-Attar, Frank Cichocki, et al.
Virchows Archiv : an International Journal of Pathology|March 17, 2026
T-prolymphocytic leukemia with three distinct immunophenotypic subsetsNana P Matsumoto, Katelynn E Davis, Nidhi Aggarwal, et al.
Pageof 5